Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127612141 | 12761214 | 1 | I | 201604 | 20160906 | 20160920 | 20160920 | EXP | US-UCBSA-2016034746 | UCB | 71.09 | YR | F | Y | 67.00000 | KG | 20160920 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127612141 | 12761214 | 1 | PS | VIMPAT | LACOSAMIDE | 1 | Oral | 100 MG, 2X/DAY (BID) (STRENGTH: 100 MG) | 22253 | 100 | MG | FILM-COATED TABLET | BID | ||||||
| 127612141 | 12761214 | 2 | SS | KEPPRA | LEVETIRACETAM | 1 | Oral | UNK | Y | U | 0 | FILM-COATED TABLET | |||||||
| 127612141 | 12761214 | 3 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, 2X/DAY (BID) (STRENGTH: 25 MG) | U | 0 | 25 | MG | TABLET | BID | |||||
| 127612141 | 12761214 | 4 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 1/2 TABLET, 2X/DAY (BID) (STRENGTH: 25 MG) | U | 0 | TABLET | BID | |||||||
| 127612141 | 12761214 | 5 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, ONCE DAILY (QD) | U | 0 | 10 | MG | TABLET | QD | |||||
| 127612141 | 12761214 | 6 | C | Asa | ASPIRIN | 1 | Oral | 81 MG, ONCE DAILY (QD) (STRENGTH: 81 MG) | U | 0 | 81 | MG | QD | ||||||
| 127612141 | 12761214 | 7 | C | Calcium | CALCIUM | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127612141 | 12761214 | 1 | Product used for unknown indication |
| 127612141 | 12761214 | 2 | Product used for unknown indication |
| 127612141 | 12761214 | 3 | Hypertension |
| 127612141 | 12761214 | 5 | Blood cholesterol increased |
| 127612141 | 12761214 | 6 | Product used for unknown indication |
| 127612141 | 12761214 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127612141 | 12761214 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127612141 | 12761214 | Amnesia | |
| 127612141 | 12761214 | Blood pressure increased | |
| 127612141 | 12761214 | Dizziness | |
| 127612141 | 12761214 | Herpes zoster | |
| 127612141 | 12761214 | Joint swelling | |
| 127612141 | 12761214 | Mood altered | |
| 127612141 | 12761214 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127612141 | 12761214 | 1 | 20160502 | 0 | ||
| 127612141 | 12761214 | 2 | 20160410 | 201605 | 0 | |
| 127612141 | 12761214 | 3 | 201606 | 201606 | 0 | |
| 127612141 | 12761214 | 4 | 201606 | 0 |